Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Intellia Therapeutics (NTLA) Interest & Investment Income: 2016-2025

Historic Interest & Investment Income for Intellia Therapeutics (NTLA) over the last 10 years, with Sep 2025 value amounting to $6.7 million.

  • Intellia Therapeutics' Interest & Investment Income fell 44.61% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.4 million, marking a year-over-year decrease of 32.81%. This contributed to the annual value of $47.8 million for FY2024, which is 4.06% down from last year.
  • Intellia Therapeutics' Interest & Investment Income amounted to $6.7 million in Q3 2025, which was down 9.29% from $7.4 million recorded in Q2 2025.
  • Intellia Therapeutics' 5-year Interest & Investment Income high stood at $12.7 million for Q3 2023, and its period low was $211,000 during Q2 2021.
  • Over the past 3 years, Intellia Therapeutics' median Interest & Investment Income value was $12.1 million (recorded in 2024), while the average stood at $10.9 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first crashed by 82.29% in 2021, then skyrocketed by 2,118.52% in 2023.
  • Quarterly analysis of 5 years shows Intellia Therapeutics' Interest & Investment Income stood at $503,000 in 2021, then spiked by 964.41% to $5.4 million in 2022, then surged by 132.70% to $12.5 million in 2023, then decreased by 14.67% to $10.6 million in 2024, then crashed by 44.61% to $6.7 million in 2025.
  • Its Interest & Investment Income was $6.7 million in Q3 2025, compared to $7.4 million in Q2 2025 and $8.6 million in Q1 2025.